COMMUNIQUÉS West-GlobeNewswire

Novozymes A/S’ annual shareholders’ meeting 2018
13/03/2018
Please read the full announcement in the attached PDF 2018_08_Novozymes_annual_shareholders_meeting_EN
CROSSJECT :Information relative au nombre de droits de vote et d'actions composant le capital social
13/03/2018
Communiqué de Presse Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 13 mars 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
2017: a year of very significant reinforcement of the cash position (€274M at 12.31.2017), with all programs in the Company's pipeline moving forward
13/03/2018
2017: a year of very significant reinforcement of the cash position (€274M at 12.31.2017), with all programs in the Company's pipeline moving forward Financial results reflect in particular the signficiant ramp-up of [...]
2017 : une année marquée par un renforcement très significatif de la trésorerie (274M€ au 31.12.2017), dans un contexte de progression importante de toutes les composantes du pipeline de la Société
13/03/2018
2017 : une année marquée par un renforcement très significatif de la trésorerie (274M€ au 31.12.2017), dans un contexte de progression importante de toutes les composantes du pipeline de la Société Résultats financiers [...]
VALNEVA Initiates Phase I Clinical Study to Evaluate Its Single-Shot Vaccine Candidate against Chikungunya
13/03/2018
Valneva Initiates Phase I Clinical Study to Evaluate Its Single-Shot Vaccine Candidate against Chikungunya Lyon (France), March 13, 2018 - Valneva SE, a fully integrated commercial stage biotech company focused on [...]
VALNEVA initie une étude clinique de Phase I pour évaluer son candidat vaccin à injection unique contre le Chikungunya
13/03/2018
Valneva initie une étude clinique de Phase I pour évaluer son candidat vaccin à injection unique contre le Chikungunya Lyon, France, 13 mars 2018 - Valneva SE ("Valneva" ou "le Groupe"), société de biotechnologie dédiée [...]
Medtronic EVP & President Hooman Hakami to Speak at Oppenheimer Healthcare Conference
13/03/2018
DUBLIN - March 13, 2018 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, today announced it will participate in the Oppenheimer 28 th Annual Healthcare Conference on Tuesday, March 20, 2018, in New [...]
Medical Prognosis Institute publishes selected financial information for the period 1 July 2017 - 31 December 2017 due to the proposed merger between Medical Prognosis Institute and Oncology Venture
13/03/2018
Hørsholm, Denmark - Medical Prognosis Institute A/S ("MPI") (Nasdaq First North Stockholm: MPI) today publishes selected financial information for the period 1 July 2017 - 31 December 2017 due to the proposed merger [...]
Shire Applies to Cease to be a Reporting Issuer in Canada
13/03/2018
Shire Applies to Cease to be a Reporting Issuer in Canada Dublin, Ireland - 13 March 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) ("Shire" or the "Company") announces that it has applied to the Autorité des marchés [...]
Immuron Progresses Discussions with Institutional Funds
13/03/2018
MELBOURNE, Australia, March 13, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ: IMRN ), an Australian microbiome biopharmaceutical company focused on developing and commercializing orally delivered targeted [...]
Gemphire Therapeutics to Announce Fourth Quarter and Year End 2017 Financial Results on Thursday, March 15
13/03/2018
LIVONIA, Mich., March 13, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders [...]
TrustedHealth Launches Global Network for Treatment of Life-Threatening Diseases, Presenting at World Health Organization
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- TrustedHealth , a blockchain-based patient and doctor-centric health ecosystem in specialized medicine, is launching to increase access to condition-specific specialists [...]
Aptevo Therapeutics Reports 2017 Financial Results and Provides Business Update
13/03/2018
Completes Sale of Hyperimmune Commercial Business for up to $74.5 Million Forms Strategic Bispecific Antibody Partnership with Alligator Bioscience Demonstrating Versatility of the ADAPTIR™ Technology Platform Advances [...]
NSS Labs Initiates Group Test Coverage of the Endpoint Detection and Response Market
13/03/2018
AUSTIN, Texas, March 13, 2018 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent, fact-based cybersecurity guidance, today announced that it is expanding on its strong foundation of [...]
Predictive Technology Group Announces Presentations of Clinical Research Relating to the Role of Genetics in Endometriosis at the Society for Reproductive Investigation Meeting
13/03/2018
SALT LAKE CITY, March 13, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTCPINK:PRED), a life-sciences technology company, today announces new clinical data relating to the role of genetics in the [...]
Exalenz Bioscience’s BreathID® Hp & BreathID Hp Lab Systems Receive FDA Clearance for Diagnosis of Helicobacter pylori Testing in Pediatric Patients
13/03/2018
MODI'IN, Israel and MANASQUAN, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Exalenz Bioscience Ltd. (TASE: EXEN ), a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of [...]
Tabula Rasa HealthCare Chief Pharmacotherapy Officer Robert L. Alesiani to Receive American Pharmacists Association’s Hugo H. Schaefer Award
13/03/2018
MOORESTOWN, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc ., (“TRHC”) (NASDAQ: TRHC ) announced today that Chief Pharmacotherapy Officer Robert L. Alesiani, PharmD, BCGP, has been named the 2018 [...]
Precipio Settles Lawsuit with Crede Capital
13/03/2018
NEW HAVEN, Conn., March 13, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO ), announced today it has settled its lawsuit with Crede Capital Group LLC, restructuring the final [...]
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray, LLC
13/03/2018
MINNEAPOLIS, March 13, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), formerly Skyline Medical, announced today that its wholly owned subsidiary, TumorGenesis Inc., [...]

Pages